GPX4 and hepatocellular carcinoma: Silencing lncRNA LINC01134 downregulated GPX4 expression, reduced GSH levels, elevated ROS and lipid ROS levels, and promoted ferroptosis, thereby sensitizing HCC cells to oxaliplatin [200].